Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review-Reference-Cited by-同舟云学术

Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review

Published:2014-06-24 Issue: Volume:93 Page:26-38
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Laros-van Gorkom Britta Antonia Petra¹,Falaise Céline²,Astermark Jan³

Affiliation:

1. Radboud University Medical Center; Nijmegen The Netherlands

2. Hemophilia Treatment Center; Marseille Cedex 05 France

3. Centre for Thrombosis and Hemostasis; Skåne University Hospital Malmö; Malmö Sweden

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12372/fullpdf

Reference57 articles.

1. Inhibitors in congenital coagulation disorders;Key;Br J Haematol,2004

2. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy;Kubisz;Med Sci Monit,2009

3. Antibodies to factor VIII. V. Patterns of immune response to factor VIII in hemophilia A;Allain;Blood,1976

4. Acquired inhibitors to the blood coagulation factors;Shapiro;Semin Thromb Hemost,1975

5. Induction of immune tolerance in haemophilia A inhibitor patients by the ‘Bonn Protocol’: predictive parameter for therapy duration and outcome;Oldenburg;Vox Sang,1999

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity of Therapeutic Biological Modalities - Lessons from Hemophilia A Therapies;Journal of Pharmaceutical Sciences;2023-09

2. Immune complications and their management in inherited and acquired bleeding disorders;Blood;2022-09-08

3. Eradication of FIX inhibitor in haemophilia B children using low‐dose immune tolerance induction with rituximab‐based immunosuppressive agent(s) in China;Haemophilia;2022-05-03

4. Nephrotic syndrome in two haemophilia B children with inhibitor under low‐dose immune tolerance induction combined with rituximab‐based immunosuppressant protocol;Haemophilia;2021-12-22

5. Eradication of factor IX neutralizing and anaphylactic inhibitors in a patient with severe haemophilia B using cyclophosphamide immune suppression and factor IX desensitization;Haemophilia;2020-01-21